image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Vistry - Partnerships division transforms growth prospects

July 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • VTY
  • Price:
  • 860p
Shares in housebuilders have taken a battering following the Covid-19 panic but recent weeks have seen a sharp bounce as investors anticipate a return to normality. One of the better placed house builders is Vistry, the new name for Bovis Homes, following its £1.075bn acquisition in January of the Linden Homes and Partnerships & Regeneration businesses from rival Galliford Try. Even before Covid, Vistry’s fortunes had improved considerably following the arrival of highly-rated CEO Greg Fitzgerald but this deal has taken the potential for share price outperformance up several notches. Not only has the deal created a top five house builder with medium term capacity to deliver more than 14,000 new homes per year b ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X